Health Care Supplies

CIRC

Circle

Conference Minutes

HSBA

00005

CRCL

DEFI

HSBC

01763

CVAC

APO-A

HSHD

<p>The following are the Minutes of the <span type="security-tag" counter_id="ST/US/C" name="Citigroup">$Citigroup(C.US)</span>ircle (CRCL.US) FY25 Q3 earnings call. For a quick interpretation, you can simply review the Quick Interpretation of the financial report. 1. Financial Core Data Review: (1) Performance Overview: USDC circulation reached $73.7 billion, a year-on-year increase of 108%; on-chain transaction volume was $9.6 trillion, a year-on-year increase of 580%. (2) Profitability: Total revenue and reserve earnings were $740 million, a year-on-year increase of 66%; Adjusted EBITDA was $166 million, a year-on-year increase of 78%. The profit margin reached 57%...</p>

Deutsche Boerse AG

HSBC Holdings Plc

HSBC HOLDINGS

Apollo Global

BlackRock

Hashdex Bitcoin Futures ETF

Ameriprise Financial

SentinelOne

Citigroup

CureVac BV

APOLLO GLOBAL MANAGEMENT INC 6.75% CONV PFD STK SER A

HSBC HK SDR 5to1

Circle (Minutes): The Ecological Network is More Important than Commercialization

CIRC Signs Strategic Cooperation Agreement with CNNC Capital

China Radiopharmaceutical Signs Gamma Irradiation Station Contract with Peru

CIRC Makes First Export of Cobalt-60 Radioisotopes to Brazil

UBS Increases Stake in China National Isotope to 5.01%

China National Nuclear Corporation's subsidiary wins a champion title in the pharmaceutical industry

China National Nuclear Corporation's Tongfu Announces Release of Carbon Isotopes and Launch of Phase II Project

China National Isotope Corporation Successfully Develops Isotope Separation Technology and Signs International Cooperation Memorandum

China National Nuclear Corporation signs isotope procurement MOU with Brazilian nuclear agency

China Isotope Holdings' Boron [10B] Phenylalanine Injection Receives CDE Acceptance

CIRC released FY2025 Q1 earnings on August 28 (BJT), actual revenue HKD 1.53 B, actual EPS HKD 0.2879

CIRC released FY2025 Semi-Annual Earnings on August 28 After-Market BJT, Actual Revenue HKD 3.094 B, Actual EPS HKD 0.5821

CIRC released FY2025 Q2 earnings on August 28 After-Market (BJT), actual revenue HKD 1.564 B, actual EPS HKD 0.2955

CIRC to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

UBS Increases Holdings in China National Isotope

UBS Increases Stake in China Isotope to 5.01%

CIRC Establishes Strategic Partnership with Anqing for Stable Isotope Industry

Han Yongjiang Resigns as Chairman of China National Isotope Corporation, Xiao Yafei Appointed as Executive Director

China Nuclear Medicine's C-14 Barium Carbonate Product Achieves Batch Export

China General Nuclear successfully mass produces Yttrium-90

China National Nuclear Corporation Signs Gamma Irradiation Facility Construction Contract in Peru

CMON

CHINAENERGY RTS

CHINA NEW HLDGS

CHI KINGSTONE

BHCC HOLDING

ST HLDGS

SHEUNG YUE GP

CENTURY GINWA

ADTIGER CORP

SHUOAO INTL

CONANT OPTICAL

KANGJI MEDICAL

INT MEDICAL

ORBUSNEICH

WEIGAO GROUP

BASECARE-B

KAISA HEALTH

ARTS OPTICAL

HUAKANG BIOMED

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio